Literature DB >> 17015782

Caveolin-dependent angiotensin II type 1 receptor signaling in vascular smooth muscle.

Masuko Ushio-Fukai1, R Wayne Alexander.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 17015782     DOI： 10.1161/01.HYP.0000242907.70697.5d

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  29 in total

1.  Early endosomal antigen 1 (EEA1) is an obligate scaffold for angiotensin II-induced, PKC-alpha-dependent Akt activation in endosomes.

Authors:  Rafal Robert Nazarewicz; Gloria Salazar; Nikolay Patrushev; Alejandra San Martin; Lula Hilenski; Shiqin Xiong; R Wayne Alexander
Journal:  J Biol Chem       Date:  2010-11-20       Impact factor: 5.157

2.  Hsp70 regulation on Nox4/p22phox and cytoskeletal integrity as an effect of losartan in vascular smooth muscle cells.

Authors:  Andrea Fernanda Gil Lorenzo; Victoria Bocanegra; María Eugenia Benardon; Valeria Cacciamani; Patricia G Vallés
Journal:  Cell Stress Chaperones       Date:  2013-06-13       Impact factor: 3.667

3.  A novel role for caveolin-1 in regulating endothelial nitric oxide synthase activation in response to H2O2 and shear stress.

Authors:  Jing Tian; Yali Hou; Qing Lu; Dean A Wiseman; Fabio Vasconcelos Fonsesca; Shawn Elms; David J Fulton; Stephen M Black
Journal:  Free Radic Biol Med       Date:  2010-03-29       Impact factor: 7.376

4.  Angiotensin (1-7) induces MAS receptor internalization.

Authors:  Mariela M Gironacci; Hugo P Adamo; Gerardo Corradi; Robson A Santos; Pablo Ortiz; Oscar A Carretero
Journal:  Hypertension       Date:  2011-06-13       Impact factor: 10.190

5.  Cooperative Role of Mineralocorticoid Receptor and Caveolin-1 in Regulating the Vascular Response to Low Nitric Oxide-High Angiotensin II-Induced Cardiovascular Injury.

Authors:  Luminita H Pojoga; Tham M Yao; Lauren A Opsasnick; Waleed T Siddiqui; Ossama M Reslan; Gail K Adler; Gordon H Williams; Raouf A Khalil
Journal:  J Pharmacol Exp Ther       Date:  2015-07-16       Impact factor: 4.030

6.  Sensitivity of NOS-dependent vascular relaxation pathway to mineralocorticoid receptor blockade in caveolin-1-deficient mice.

Authors:  Luminita H Pojoga; Zuzana Adamová; Abhinav Kumar; Amanda K Stennett; Jose R Romero; Gail K Adler; Gordon H Williams; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-02       Impact factor: 4.733

7.  Caveolin-1 Deletion Prevents Hypertensive Vascular Remodeling Induced by Angiotensin II.

Authors:  Steven J Forrester; Katherine J Elliott; Tatsuo Kawai; Takashi Obama; Michael J Boyer; Kyle J Preston; Zhen Yan; Satoru Eguchi; Victor Rizzo
Journal:  Hypertension       Date:  2016-11-28       Impact factor: 10.190

8.  Caveolin 1 is critical for abdominal aortic aneurysm formation induced by angiotensin II and inhibition of lysyl oxidase.

Authors:  Takehiko Takayanagi; Kevin J Crawford; Tomonori Kobayashi; Takashi Obama; Toshiyuki Tsuji; Katherine J Elliott; Tomoki Hashimoto; Victor Rizzo; Satoru Eguchi
Journal:  Clin Sci (Lond)       Date:  2014-06       Impact factor: 6.124

Review 9.  Signaling components of redox active endosomes: the redoxosomes.

Authors:  Fredrick D Oakley; Duane Abbott; Qiang Li; John F Engelhardt
Journal:  Antioxid Redox Signal       Date:  2009-06       Impact factor: 8.401

10.  Dissociation of hyperglycemia from altered vascular contraction and relaxation mechanisms in caveolin-1 null mice.

Authors:  Luminita H Pojoga; Tham M Yao; Lauren A Opsasnick; Amanda E Garza; Ossama M Reslan; Gail K Adler; Gordon H Williams; Raouf A Khalil
Journal:  J Pharmacol Exp Ther       Date:  2013-11-26       Impact factor: 4.030
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.